Design, synthesis and structure-activity relationships of a novel class of sulfonylpyridine inhibitors of Interleukin-2 inducible T-cell kinase (ITK)
Starting from benzylpyrimidine 2, molecular modeling and X-ray crystallography were used to design highly potent inhibitors of Interleukin-2 inducible T-cell kinase (ITK). Sulfonylpyridine 4i showed sub-nanomolar affinity against ITK, was selective versus Lck and its activity in the Jurkat cell-base...
Gespeichert in:
Veröffentlicht in: | Bioorganic & medicinal chemistry letters 2014-12, Vol.24 (24), p.5818-5823 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 5823 |
---|---|
container_issue | 24 |
container_start_page | 5818 |
container_title | Bioorganic & medicinal chemistry letters |
container_volume | 24 |
creator | Trani, Giancarlo Barker, John J Bromidge, Steven M Brookfield, Frederick A Burch, Jason D Chen, Yuan Eigenbrot, Charles Heifetz, Alexander Ismaili, M Hicham A Johnson, Adam Krülle, Thomas M MacKinnon, Colin H Maghames, Rosemary McEwan, Paul A Montalbetti, Christian A G N Ortwine, Daniel F Pérez-Fuertes, Yolanda Vaidya, Darshan G Wang, Xiaolu Zarrin, Ali A Pei, Zhonghua |
description | Starting from benzylpyrimidine 2, molecular modeling and X-ray crystallography were used to design highly potent inhibitors of Interleukin-2 inducible T-cell kinase (ITK). Sulfonylpyridine 4i showed sub-nanomolar affinity against ITK, was selective versus Lck and its activity in the Jurkat cell-based assay was greatly improved over 2. |
doi_str_mv | 10.1016/j.bmcl.2014.10.020 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1660393994</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1660393994</sourcerecordid><originalsourceid>FETCH-LOGICAL-c336t-9f8269d17187c15c2ffb2b86d243f530603774114e6578b76975a9e79c1e15d33</originalsourceid><addsrcrecordid>eNqNkc1q3DAUhUVpaKZpXqCLomUK9UT_spYl_RsayGYK2RlZvu5oqpGnkhzwg_R9Yydp1lndyznnHi58CL2nZE0JVZf7dXtwYc0IFbOwJoy8QisqlKi4IPI1WhGjSFUbcXuK3ua8J3OQCPEGnTIppBRGr9C_L5D97_gJ5ymW3bxnbGOHc0mjK2OCyrri73yZcIJgix9i3vljxkOPLY7DHQTsgs0PQh5DP8QpHKfkOx8B-7jzrS9DerA3sUAKMP7xsWKz143OtwHwtnIQAp5lmwFfbLY_P75DJ70NGc6f5hn69e3r9upHdX3zfXP1-bpynKtSmb5mynRU01o7Kh3r-5a1teqY4L3kRBGutaBUgJK6brUyWloD2jgKVHacn6GLx95jGv6OkEtz8Hn5xkYYxtxQNVcYbox4QZQZo7Sslyh7jLo05Jygb47JH2yaGkqahVyzbxZyzUJu0WZy89GHp_6xPUD3fPIfFb8HhTiWvg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1629967584</pqid></control><display><type>article</type><title>Design, synthesis and structure-activity relationships of a novel class of sulfonylpyridine inhibitors of Interleukin-2 inducible T-cell kinase (ITK)</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Trani, Giancarlo ; Barker, John J ; Bromidge, Steven M ; Brookfield, Frederick A ; Burch, Jason D ; Chen, Yuan ; Eigenbrot, Charles ; Heifetz, Alexander ; Ismaili, M Hicham A ; Johnson, Adam ; Krülle, Thomas M ; MacKinnon, Colin H ; Maghames, Rosemary ; McEwan, Paul A ; Montalbetti, Christian A G N ; Ortwine, Daniel F ; Pérez-Fuertes, Yolanda ; Vaidya, Darshan G ; Wang, Xiaolu ; Zarrin, Ali A ; Pei, Zhonghua</creator><creatorcontrib>Trani, Giancarlo ; Barker, John J ; Bromidge, Steven M ; Brookfield, Frederick A ; Burch, Jason D ; Chen, Yuan ; Eigenbrot, Charles ; Heifetz, Alexander ; Ismaili, M Hicham A ; Johnson, Adam ; Krülle, Thomas M ; MacKinnon, Colin H ; Maghames, Rosemary ; McEwan, Paul A ; Montalbetti, Christian A G N ; Ortwine, Daniel F ; Pérez-Fuertes, Yolanda ; Vaidya, Darshan G ; Wang, Xiaolu ; Zarrin, Ali A ; Pei, Zhonghua</creatorcontrib><description>Starting from benzylpyrimidine 2, molecular modeling and X-ray crystallography were used to design highly potent inhibitors of Interleukin-2 inducible T-cell kinase (ITK). Sulfonylpyridine 4i showed sub-nanomolar affinity against ITK, was selective versus Lck and its activity in the Jurkat cell-based assay was greatly improved over 2.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2014.10.020</identifier><identifier>PMID: 25455497</identifier><language>eng</language><publisher>England</publisher><subject>Binding Sites ; Crystallography, X-Ray ; Drug Design ; Kinetics ; Molecular Dynamics Simulation ; Protein Binding ; Protein Kinase Inhibitors - chemical synthesis ; Protein Kinase Inhibitors - chemistry ; Protein Kinase Inhibitors - metabolism ; Protein Structure, Tertiary ; Protein-Tyrosine Kinases - antagonists & inhibitors ; Protein-Tyrosine Kinases - metabolism ; Pyrazoles - chemistry ; Pyridines - chemical synthesis ; Pyridines - chemistry ; Pyridines - metabolism ; Structure-Activity Relationship ; Sulfones - chemistry</subject><ispartof>Bioorganic & medicinal chemistry letters, 2014-12, Vol.24 (24), p.5818-5823</ispartof><rights>Copyright © 2014 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c336t-9f8269d17187c15c2ffb2b86d243f530603774114e6578b76975a9e79c1e15d33</citedby><cites>FETCH-LOGICAL-c336t-9f8269d17187c15c2ffb2b86d243f530603774114e6578b76975a9e79c1e15d33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25455497$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Trani, Giancarlo</creatorcontrib><creatorcontrib>Barker, John J</creatorcontrib><creatorcontrib>Bromidge, Steven M</creatorcontrib><creatorcontrib>Brookfield, Frederick A</creatorcontrib><creatorcontrib>Burch, Jason D</creatorcontrib><creatorcontrib>Chen, Yuan</creatorcontrib><creatorcontrib>Eigenbrot, Charles</creatorcontrib><creatorcontrib>Heifetz, Alexander</creatorcontrib><creatorcontrib>Ismaili, M Hicham A</creatorcontrib><creatorcontrib>Johnson, Adam</creatorcontrib><creatorcontrib>Krülle, Thomas M</creatorcontrib><creatorcontrib>MacKinnon, Colin H</creatorcontrib><creatorcontrib>Maghames, Rosemary</creatorcontrib><creatorcontrib>McEwan, Paul A</creatorcontrib><creatorcontrib>Montalbetti, Christian A G N</creatorcontrib><creatorcontrib>Ortwine, Daniel F</creatorcontrib><creatorcontrib>Pérez-Fuertes, Yolanda</creatorcontrib><creatorcontrib>Vaidya, Darshan G</creatorcontrib><creatorcontrib>Wang, Xiaolu</creatorcontrib><creatorcontrib>Zarrin, Ali A</creatorcontrib><creatorcontrib>Pei, Zhonghua</creatorcontrib><title>Design, synthesis and structure-activity relationships of a novel class of sulfonylpyridine inhibitors of Interleukin-2 inducible T-cell kinase (ITK)</title><title>Bioorganic & medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>Starting from benzylpyrimidine 2, molecular modeling and X-ray crystallography were used to design highly potent inhibitors of Interleukin-2 inducible T-cell kinase (ITK). Sulfonylpyridine 4i showed sub-nanomolar affinity against ITK, was selective versus Lck and its activity in the Jurkat cell-based assay was greatly improved over 2.</description><subject>Binding Sites</subject><subject>Crystallography, X-Ray</subject><subject>Drug Design</subject><subject>Kinetics</subject><subject>Molecular Dynamics Simulation</subject><subject>Protein Binding</subject><subject>Protein Kinase Inhibitors - chemical synthesis</subject><subject>Protein Kinase Inhibitors - chemistry</subject><subject>Protein Kinase Inhibitors - metabolism</subject><subject>Protein Structure, Tertiary</subject><subject>Protein-Tyrosine Kinases - antagonists & inhibitors</subject><subject>Protein-Tyrosine Kinases - metabolism</subject><subject>Pyrazoles - chemistry</subject><subject>Pyridines - chemical synthesis</subject><subject>Pyridines - chemistry</subject><subject>Pyridines - metabolism</subject><subject>Structure-Activity Relationship</subject><subject>Sulfones - chemistry</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc1q3DAUhUVpaKZpXqCLomUK9UT_spYl_RsayGYK2RlZvu5oqpGnkhzwg_R9Yydp1lndyznnHi58CL2nZE0JVZf7dXtwYc0IFbOwJoy8QisqlKi4IPI1WhGjSFUbcXuK3ua8J3OQCPEGnTIppBRGr9C_L5D97_gJ5ymW3bxnbGOHc0mjK2OCyrri73yZcIJgix9i3vljxkOPLY7DHQTsgs0PQh5DP8QpHKfkOx8B-7jzrS9DerA3sUAKMP7xsWKz143OtwHwtnIQAp5lmwFfbLY_P75DJ70NGc6f5hn69e3r9upHdX3zfXP1-bpynKtSmb5mynRU01o7Kh3r-5a1teqY4L3kRBGutaBUgJK6brUyWloD2jgKVHacn6GLx95jGv6OkEtz8Hn5xkYYxtxQNVcYbox4QZQZo7Sslyh7jLo05Jygb47JH2yaGkqahVyzbxZyzUJu0WZy89GHp_6xPUD3fPIfFb8HhTiWvg</recordid><startdate>20141215</startdate><enddate>20141215</enddate><creator>Trani, Giancarlo</creator><creator>Barker, John J</creator><creator>Bromidge, Steven M</creator><creator>Brookfield, Frederick A</creator><creator>Burch, Jason D</creator><creator>Chen, Yuan</creator><creator>Eigenbrot, Charles</creator><creator>Heifetz, Alexander</creator><creator>Ismaili, M Hicham A</creator><creator>Johnson, Adam</creator><creator>Krülle, Thomas M</creator><creator>MacKinnon, Colin H</creator><creator>Maghames, Rosemary</creator><creator>McEwan, Paul A</creator><creator>Montalbetti, Christian A G N</creator><creator>Ortwine, Daniel F</creator><creator>Pérez-Fuertes, Yolanda</creator><creator>Vaidya, Darshan G</creator><creator>Wang, Xiaolu</creator><creator>Zarrin, Ali A</creator><creator>Pei, Zhonghua</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20141215</creationdate><title>Design, synthesis and structure-activity relationships of a novel class of sulfonylpyridine inhibitors of Interleukin-2 inducible T-cell kinase (ITK)</title><author>Trani, Giancarlo ; Barker, John J ; Bromidge, Steven M ; Brookfield, Frederick A ; Burch, Jason D ; Chen, Yuan ; Eigenbrot, Charles ; Heifetz, Alexander ; Ismaili, M Hicham A ; Johnson, Adam ; Krülle, Thomas M ; MacKinnon, Colin H ; Maghames, Rosemary ; McEwan, Paul A ; Montalbetti, Christian A G N ; Ortwine, Daniel F ; Pérez-Fuertes, Yolanda ; Vaidya, Darshan G ; Wang, Xiaolu ; Zarrin, Ali A ; Pei, Zhonghua</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c336t-9f8269d17187c15c2ffb2b86d243f530603774114e6578b76975a9e79c1e15d33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Binding Sites</topic><topic>Crystallography, X-Ray</topic><topic>Drug Design</topic><topic>Kinetics</topic><topic>Molecular Dynamics Simulation</topic><topic>Protein Binding</topic><topic>Protein Kinase Inhibitors - chemical synthesis</topic><topic>Protein Kinase Inhibitors - chemistry</topic><topic>Protein Kinase Inhibitors - metabolism</topic><topic>Protein Structure, Tertiary</topic><topic>Protein-Tyrosine Kinases - antagonists & inhibitors</topic><topic>Protein-Tyrosine Kinases - metabolism</topic><topic>Pyrazoles - chemistry</topic><topic>Pyridines - chemical synthesis</topic><topic>Pyridines - chemistry</topic><topic>Pyridines - metabolism</topic><topic>Structure-Activity Relationship</topic><topic>Sulfones - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Trani, Giancarlo</creatorcontrib><creatorcontrib>Barker, John J</creatorcontrib><creatorcontrib>Bromidge, Steven M</creatorcontrib><creatorcontrib>Brookfield, Frederick A</creatorcontrib><creatorcontrib>Burch, Jason D</creatorcontrib><creatorcontrib>Chen, Yuan</creatorcontrib><creatorcontrib>Eigenbrot, Charles</creatorcontrib><creatorcontrib>Heifetz, Alexander</creatorcontrib><creatorcontrib>Ismaili, M Hicham A</creatorcontrib><creatorcontrib>Johnson, Adam</creatorcontrib><creatorcontrib>Krülle, Thomas M</creatorcontrib><creatorcontrib>MacKinnon, Colin H</creatorcontrib><creatorcontrib>Maghames, Rosemary</creatorcontrib><creatorcontrib>McEwan, Paul A</creatorcontrib><creatorcontrib>Montalbetti, Christian A G N</creatorcontrib><creatorcontrib>Ortwine, Daniel F</creatorcontrib><creatorcontrib>Pérez-Fuertes, Yolanda</creatorcontrib><creatorcontrib>Vaidya, Darshan G</creatorcontrib><creatorcontrib>Wang, Xiaolu</creatorcontrib><creatorcontrib>Zarrin, Ali A</creatorcontrib><creatorcontrib>Pei, Zhonghua</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Bioorganic & medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Trani, Giancarlo</au><au>Barker, John J</au><au>Bromidge, Steven M</au><au>Brookfield, Frederick A</au><au>Burch, Jason D</au><au>Chen, Yuan</au><au>Eigenbrot, Charles</au><au>Heifetz, Alexander</au><au>Ismaili, M Hicham A</au><au>Johnson, Adam</au><au>Krülle, Thomas M</au><au>MacKinnon, Colin H</au><au>Maghames, Rosemary</au><au>McEwan, Paul A</au><au>Montalbetti, Christian A G N</au><au>Ortwine, Daniel F</au><au>Pérez-Fuertes, Yolanda</au><au>Vaidya, Darshan G</au><au>Wang, Xiaolu</au><au>Zarrin, Ali A</au><au>Pei, Zhonghua</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Design, synthesis and structure-activity relationships of a novel class of sulfonylpyridine inhibitors of Interleukin-2 inducible T-cell kinase (ITK)</atitle><jtitle>Bioorganic & medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2014-12-15</date><risdate>2014</risdate><volume>24</volume><issue>24</issue><spage>5818</spage><epage>5823</epage><pages>5818-5823</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>Starting from benzylpyrimidine 2, molecular modeling and X-ray crystallography were used to design highly potent inhibitors of Interleukin-2 inducible T-cell kinase (ITK). Sulfonylpyridine 4i showed sub-nanomolar affinity against ITK, was selective versus Lck and its activity in the Jurkat cell-based assay was greatly improved over 2.</abstract><cop>England</cop><pmid>25455497</pmid><doi>10.1016/j.bmcl.2014.10.020</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0960-894X |
ispartof | Bioorganic & medicinal chemistry letters, 2014-12, Vol.24 (24), p.5818-5823 |
issn | 0960-894X 1464-3405 |
language | eng |
recordid | cdi_proquest_miscellaneous_1660393994 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Binding Sites Crystallography, X-Ray Drug Design Kinetics Molecular Dynamics Simulation Protein Binding Protein Kinase Inhibitors - chemical synthesis Protein Kinase Inhibitors - chemistry Protein Kinase Inhibitors - metabolism Protein Structure, Tertiary Protein-Tyrosine Kinases - antagonists & inhibitors Protein-Tyrosine Kinases - metabolism Pyrazoles - chemistry Pyridines - chemical synthesis Pyridines - chemistry Pyridines - metabolism Structure-Activity Relationship Sulfones - chemistry |
title | Design, synthesis and structure-activity relationships of a novel class of sulfonylpyridine inhibitors of Interleukin-2 inducible T-cell kinase (ITK) |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T23%3A29%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Design,%20synthesis%20and%20structure-activity%20relationships%20of%20a%20novel%20class%20of%20sulfonylpyridine%20inhibitors%20of%20Interleukin-2%20inducible%20T-cell%20kinase%20(ITK)&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Trani,%20Giancarlo&rft.date=2014-12-15&rft.volume=24&rft.issue=24&rft.spage=5818&rft.epage=5823&rft.pages=5818-5823&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2014.10.020&rft_dat=%3Cproquest_cross%3E1660393994%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1629967584&rft_id=info:pmid/25455497&rfr_iscdi=true |